Christopher M Scott

US Patent:

8285506, Oct 9, 2012

Filed:

Feb 2, 2010

Appl. No.:

12/698441

Inventors:

Christopher Adam Oldham - High Point NC, US
Christopher Eric Scott - High Point NC, US
Juergen Voss - Borchen, DE

Assignee:

Gilbarco Inc. - Greensboro NC

International Classification:

G01F 25/00
G06F 19/00

US Classification:

702 85, 702 45, 702 46, 702 50, 702 55, 702100, 222 71, 222 23, 700240

Abstract:

An apparatus for generating a measure of fluid. The apparatus comprises a flow meter and a pulser having an identifier and a memory. The pulser is associated with the flow meter for generating pulser data indicative of a volume of fluid delivered through the flow meter. The pulser may alter the pulser data using correction data stored in its memory to generate altered pulser data. The pulser may store at least one of the pulser data and the altered pulser data in the memory. The apparatus further comprises a switch operatively connected to the pulser's memory. The switch is operative to vary the memory of the pulser between a write-protected and a write-enabled mode. Also, the apparatus comprises a controller in communication with the pulser and a serial communication circuit which enables communication between the pulser and the controller. Communication between the controller and the pulser includes the identifier.

US Patent:

20200317883, Oct 8, 2020

Filed:

Nov 19, 2018

Appl. No.:

16/765277

Inventors:

- Charlotte NC, US
Christopher Scott - Raleigh NC, US
Amber C. Rumple - Greenville SC, US

International Classification:

C08J 9/30
C08F 220/14
C08J 9/00
C08F 222/20
C08J 9/14

Abstract:

The presently disclosed subject matter is directed to a method of making a foam, specifically, the development of isocyanate-free foams using at least one unsaturated polyester. The at least one unsaturated polyester is a reaction product of at least one unsaturated cyclic anhydride, dicyclopentadiene, and at least one polyol. The disclosed formulation further comprises at least one reactive diluent and at least one initiator. The disclosed formulations are cured by a free radical mechanism.